Take this moment to learn about the VALOR Study, a clinical trial now enrolling people living with ALS caused by a genetic change (mutation) in the superoxide dismutase 1 (SOD1) gene. The clinical trial is evaluating the safety and potential efficacy of an investigational drug to see if it may help slow the progression of SOD1-ALS.
Potential study participants must:
Be 18 years of age
caused by ALS
Agree to genetic testing
for the SOD1 mutation
Choosing to take part in a clinical trial is a big decision. It is important for you to understand what the trial is about, the potential risks, and what your participation would involve before agreeing to take part.